Tomographic aspects of common variable immunodeficiency suggestive of lymphocytic granulomatous interstitial lung disease: a systematic review
PDF

Palavras-chave

common variable immunodeficiency
lung diseases, interstitial
bronchiolitis
tomography, x ray computed

Como Citar

Costa Amaral de Sousa, L., Amorim, C. A., Hunt, S. de O., Santana, J. S. de, Marques, D. de S., & Motta, D. de L. (2025). Tomographic aspects of common variable immunodeficiency suggestive of lymphocytic granulomatous interstitial lung disease: a systematic review. Brazilian Journal of Implantology and Health Sciences, 7(2), 2161–2171. https://doi.org/10.36557/2674-8169.2025v7n2p2161-2171

Resumo

Objective: Common variable immunodeficiency (CVID) is a primary antibody deficiency characterised by hypogammaglobulinemia, leading to the occurrence of infections and at times, the development of diffuse lesions with granulomatous characteristics and lymphoproliferative histopathological patterns. Granulomatous lymphocytic interstitial lung disease (GLILD) is a rare form of interstitial lung disease where imaging exams play a crucial role, therefore this article aims to assess the prevalence of tomographic findings and evaluate whether bronchiolitis and ground glass opacity are suggestive findings for the diagnosis of GLILD in patients with CVID without a previous GLILD diagnosis. Method: a systematic review using the prisma methodology was conducted with five descriptors across four databases, covering publications from 2012 to 2022 in the portuguese, english, and spanish languages. Results: out of 234 initial results, 26 articles were included, representing a total of 775 analysed CVID patients. Various radiographic abnormalities were identified, with notable findings including bronchiectasis, pneumonia, atelectasis, among others. Conclusion: the results indicate that it is not possible to establish a pattern of tomographic findings, demonstrating the heterogeneity in the presentation of glild.

https://doi.org/10.36557/2674-8169.2025v7n2p2161-2171
PDF

Referências

Bonilla FA & Geha RS: Update on Primary Immunodeficiency Diseases. J Allergy Clin Immunol. 2006;117:S435-41.

Lopes JP, Ho HE, Cunningham-Rundles C. Interstitial Lung Disease in Common Variable Immunodeficiency. Front Immunol. 2021 Mar 11;12:605945. doi: 10.3389/fimmu.2021.605945. PMID: 33776995; PMCID: PMC7990881.

AVALOS, José de Jesus Rivas. Immunophenotypic characterization of memory B cells in patients with IgA deficiency and common variable immunodeficiency. 2009. Dissertation (Master's in Allergy and Immunopathology) - Faculty of Medicine, University of São Paulo, São Paulo, 2009. doi:10.11606/D.5.2009.tde-03022010-165217. Accessed on: 2023-07-31.

Geha RS, Notarangelo LD, Casanova JL, Chapel H, Conley ME, Fischer A, Hammarström L, Nonoyama S, Ochs HD, Puck JM, Roifman C, Seger R, Wedgwood J; International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol. 2007 Oct;120(4):776-94. doi: 10.1016/j.jaci.2007.08.053. PMID: 17952897; PMCID: PMC2601718.

Kokron CM, Errante PR, Barros MT, Baracho GV, Camargo MM, Kalil J, Rizzo LV. Clinical and laboratory aspects of common variable immunodeficiency. An Acad Bras Cienc. 2004 Dec;76(4):707-26. doi: 10.1590/s0001-37652004000400007. Epub 2004 Nov 16. PMID: 15558152.

Hurst JR, Verma N, Lowe D, Baxendale HE, Jolles S, Kelleher P, Longhurst HJ, Patel SY, Renzoni EA, Sander CR, Avery GR, Babar JL, Buckland MS, Burns S, Egner W, Gompels MM, Gordins P, Haddock JA, Hart SP, Hayman GR, Herriot R, Hoyles RK, Huissoon AP, Jacob J, Nicholson AG, Rassl DM, Sargur RB, Savic S, Seneviratne SL, Sheaff M, Vaitla PM, Walters GI, Whitehouse JL, Wright PA, Condliffe AM. British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition, Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):938-945. doi: 10.1016/j.jaip.2017.01.021. Epub 2017 Mar 25. PMID: 28351785.

Khalili M, Farzi H, Darougar S, Hajijoo F, Mesdaghi M, Mansouri M, Babaie D, Hashemitari A, Eslami N, Chavoshzadeh Z. Pulmonary Radiological Manifestations of Humoral and Combined Immunodeficiencies in a Tertiary Pediatric Center. Iran J Allergy Asthma Immunol. 2021;20(6):693-699.

Munn Z, Stern C, Aromataris E, Lockwood C, Jordan Z. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med Res Methodol. 2018 Jan 10;18(1):5. doi: 10.1186/s12874-017-0468-4. PMID: 29316881; PMCID: PMC5761190.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 2009; 339 :b2700.

Bates CA, Ellison MC, Lynch DA, Cool CD, Brown KK, Routes JM. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J Allergy Clin Immunol. 2004 Aug;114(2):415-21. doi: 10.1016/j.jaci.2004.05.057. PMID: 15316526.

Perlman DM, Sudheendra MT, Racilla E, Allen TL, Joshi A, Bhargava M. Granulomatous-Lymphocytic Interstitial Lung Disease Mimicking Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2021;38(3):e2021025. doi: 10.36141/svdld.v38i3.11114. Epub 2021 Sep 30. PMID: 34744421; PMCID: PMC8552568.

Lorenzini T, Fliegauf M, Klammer N, Frede N, Proietti M, Bulashevska A, Camacho-Ordonez N, Varjosalo M, Kinnunen M, de Vries E, van der Meer JWM, Ameratunga R, Roifman CM, Schejter YD, Kobbe R, Hautala T, Atschekzei F, Schmidt RE, Schröder C, Stepensky P, Shadur B, Pedroza LA, van der Flier M, Martínez-Gallo M, Gonzalez-Granado LI, Allende LM, Shcherbina A, Kuzmenko N, Zakharova V, Neves JF, Svec P, Fischer U, Ip W, Bartsch O, Barış S, Klein C, Geha R, Chou J, Alosaimi M, Weintraub L, Boztug K, Hirschmugl T, Dos Santos Vilela MM, Holzinger D, Seidl M, Lougaris V, Plebani A, Alsina L, Piquer-Gibert M, Deyà-Martínez A, Slade CA, Aghamohammadi A, Abolhassani H, Hammarström L, Kuismin O, Helminen M, Allen HL, Thaventhiran JE, Freeman AF, Cook M, Bakhtiar S, Christiansen M, Cunningham-Rundles C, Patel NC, Rae W, Niehues T, Brauer N, Syrjänen J, Seppänen MRJ, Burns SO, Tuijnenburg P, Kuijpers TW; NIHR BioResource; Warnatz K, Grimbacher B; NIHR BioResource. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J Allergy Clin Immunol. 2020 Oct;146(4):901-911. doi: 10.1016/j.jaci.2019.11.051. Epub 2020 Apr 9. Erratum in: J Allergy Clin Immunol. 2021 Nov;148(5):1345. PMID: 32278790; PMCID: PMC8246418.

Creative Commons License
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.

Copyright (c) 2025 Lucas Costa Amaral de Sousa, Caroline Alencar Amorim, Shannon de Oliveira Hunt, Juliana Silva de Santana, Danilo de Santana Marques, Daniela de Lucena Motta

Downloads

Não há dados estatísticos.